1.13
price down icon6.61%   -0.08
after-market Dopo l'orario di chiusura: 1.18 0.05 +4.42%
loading

Prelude Therapeutics Inc Azioni (PRLD) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- 4.00 3.00 -
Operating Expenses
6.97%
32.19
34.61 37.83 37.38 37.16
Operating Income/Loss
6.97%
-32.19
-34.61 -33.83 -34.38 -37.16
Income/Loss From Continuing Operations Before Tax
2.66%
-31.23
-32.09 -28.73 3.00 -34.74
Income/Loss From Continuing Operations After Tax
2.66%
-31.23
-32.09 -28.73 -32.27 -34.74
Net Income/Loss
2.66%
-31.23
-32.09 -28.73 -32.27 -34.74
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.01%
75.99
75.99 0.0209 75.86 75.76
Diluted Average Shares
0.01%
75.99
75.99 0.0209 75.86 75.76
Basic Earnings Per Share
2.38%
-0.41
-0.42 -0.38 -0.43 -0.46
Diluted Earnings Per Share
2.38%
-0.41
-0.42 -0.38 -0.43 -0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
Capitalizzazione:     |  Volume (24 ore):